EXTON, PA — West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Board of Directors has approved a first-quarter 2025 dividend of $0.21 per share.
The dividend is scheduled for payment on February 11, 2025, to shareholders of record as of February 7, 2025. This decision reflects West’s continued commitment to delivering value to its investors.
Headquartered in Exton, Pennsylvania, West reported $2.95 billion in net sales for fiscal year 2023, underscoring its strong financial performance. The company is part of the S&P 500 index and trades on the New York Stock Exchange under the ticker symbol WST.
This move highlights West’s robust financial health and steady focus on rewarding its shareholders while driving innovation in its industry.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.